E
Amarin Corporation plc AMRN
$9.30 $0.272.99%
Recommendation
Sell
Prev Close
$9.03
Volume
296,247
Avg Vol (90D)
79,623
Market Cap
$3.74B
Dividend & Yield
--
52-Week Range
$7.08 - $21.00
P/E (TTM)
--
EPS (TTM)
-$0.2016
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Amarin Corporation (AMRN) Welcomes New Board Member to Enhance Value
4/11/2025 - GuruFocus
Amarin (AMRN) Announces ADS Ratio Change to Meet Nasdaq Requirements
4/11/2025 - GuruFocus
Amarin (NASDAQ:AMRN) Reaches New 12-Month Low - Should You Sell?
4/11/2025 - Ticker Report
Amarin trading halted, news pending
4/10/2025 - TipRanks Financial Blog
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change AMRN Stock News
4/9/2025 - GuruFocus
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
4/9/2025 - GuruFocus
Amarin confirms effective data for 1-for-20 ADS ratio change
4/9/2025 - TipRanks Financial Blog
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
4/9/2025 - Globe Newswire
StockNews.com Begins Coverage on Amarin (NASDAQ:AMRN)
4/9/2025 - MarketBeat
Amarin Appoints JEC Capital Partners' Michael Torok to Board of Directors
4/7/2025 - GuruFocus
Amarin Appoints JEC Capital Partners' Michael Torok to Board of Directors
4/7/2025 - Globe Newswire
Amarin (NASDAQ:AMRN) Earns Sell Rating from Analysts at StockNews.com
4/3/2025 - Zolmax
Amarin (NASDAQ:AMRN) Shares to Reverse Split on Friday, April 11th
4/3/2025 - Ticker Report
Amarin Co. plc (NASDAQ:AMRN) Short Interest Update
3/31/2025 - Ticker Report
Amarin presents data at ACC.25 on EPA in lipoprotein-enriched plasma
3/31/2025 - TipRanks Financial Blog
Amarin Highlights Recent Data Presented at ACC. ...
3/31/2025 - GuruFocus
Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
3/31/2025 - Globe Newswire
Amarin (NASDAQ:AMRN) Earns Sell Rating from Analysts at StockNews.com
3/31/2025 - MarketBeat
Amarin Announces Board Member Departure Ahead of 2025 Meeting
3/28/2025 - TipRanks Financial Blog
Amarin Stock Set to Reverse Split on Friday, April 11th (NASDAQ:AMRN)
3/26/2025 - MarketBeat
Amarin (NASDAQ:AMRN) Earns Sell Rating from Analysts at StockNews.com
3/26/2025 - Ticker Report
Amarin (NASDAQ:AMRN) Coverage Initiated by Analysts at StockNews.com
3/23/2025 - MarketBeat
Amarin gains amid shareholder group push for strategic review
3/19/2025 - Seeking Alpha - Healthcare
Amarin announces additional in vitro data with EPA to be presented
3/19/2025 - TipRanks Financial Blog
New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo
3/19/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
$228.61M
EBITDA (TTM)
-$52.31M
EBIT (TTM)
-$55.32M
Net Income (TTM)
-$82.18M
Balance Sheet
Total Assets (Q)
$685.35M
Total Debt (Q)
$9.67M
Total Liabilities (Q)
$199.17M
Book Value Per Share (Q)
$1.18
Cash Flow
Cash from Operations (TTM)
-$31.02M
Cash from Investing (TTM)
-$45.98M
Cash from Financing (TTM)
-$1.44M
Net Change in Cash (TTM)
-$78.44M
Filings
Filing Date
Wednesday, March 12, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
1.73
7-Day Total Return
7.64%
30-Day Total Return
-14.19%
60-Day Total Return
-17.63%
90-Day Total Return
-8.23%
Year to Date Total Return
-11.19%
1-Year Total Return
-54.41%
2-Year Total Return
-67.25%
3-Year Total Return
-86.12%
5-Year Total Return
-92.72%
52-week Low
Mar 12, 2025 - $7.08
52-week High
Apr 11, 2024 - $21.00
Valuation
Market Cap
$3.74B - Mid Cap
Enterprise Value
$3.46B
Price/Sales (TTM)
16.25
Price/Book (Q)
7.64
Dividends and Shares
Shares Outstanding
411.29M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.amarincorp.com
Phone Number
353 0 166 99020
Address
One Central Plaza
5th Floor - 36 Dame Street
Dublin 2, D02 K7K5
Country
Ireland
Year Founded
1989
Business Description
Sector
--
Industry
--
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and... more
NASDAQ 04/11/2025 4:00PM Eastern Quotes delayed
Weiss Ratings